Discover 1,438 paid clinical trials in Tacoma, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,438
Active & Responsive
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
for
Mesial Temporal Lobe Epilepsy
Location: Seattle WA, Portland OR, Sacramento CA,
Sponsor: Neurona Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05135091
Phase3, Recruiting
Active & Responsive
Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
for
Diabetes Mellitus, Type 2,
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 40 - 65
Code: NCT05780905
Recruiting
Active & Responsive
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
for
Treatment Resistant Depression
Location: Mercer Island WA, Seattle WA, Salt Lake City UT,
Sponsor: LivaNova
Sex: All
Age: 18+
Code: NCT03887715
Recruiting
Active & Responsive
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
for
Post Traumatic Stress Disorder
Location: Seattle WA, Draper UT, Orem UT, Los Angeles CA,
Sponsor: Transcend Therapeutics
Sex: All
Age: 18+
Code: NCT07456696
Phase3, Recruiting
Active & Responsive
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
for
Major Depressive Disorder (MDD), Depression in Adults,
Location: Seattle WA, Las Vegas NV, Glendale CA, Los Angeles CA,
Sponsor: Cybin IRL Limited
Sex: All
Age: 18 - 70+
Code: NCT06793397
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Seattle WA, Edmonds WA, Vancouver WA, Portland OR,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase2, Phase3, Recruiting
Active & Responsive
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
for
Human Immunodeficiency Virus (HIV),
Location: Seattle WA, San Francisco CA, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 16+
Code: NCT07044297
Phase3, Recruiting
Active & Responsive
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70
Code: NCT05719441
Phase2, Recruiting
Active & Responsive
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
for
Relapsing Multiple Sclerosis,
Location: Seattle WA, Portland OR, Palo Alto CA, Aurora CO,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 55
Code: NCT04047628
Phase3, Recruiting
Active & Responsive
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
for
HIV-1-infection
Location: Seattle WA, San Francisco CA, Salt Lake City UT,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07645287
Phase2, Recruiting
Active & Responsive
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
for
Amyotrophic Lateral Sclerosis
Location: Seattle WA, Edmonton, San Francisco CA, Aurora CO,
Sponsor: Prilenia
Sex: All
Age: 18 - 70+
Code: NCT07322003
Phase3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Seattle WA, Issaquah WA, Edmonds WA, Vancouver WA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase3, Recruiting
Active & Responsive
Assessment of CCM in HF With Higher Ejection Fraction
for
Heart Failure, Heart Failure With Preserved Ejection Fraction,
Location: Seattle WA, Vancouver WA, Portland OR, Concord CA,
Sponsor: Impulse Dynamics
Sex: All
Age: 18+
Code: NCT05064709
Recruiting
Active & Responsive
Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL
for
CLL/SLL
Location: Seattle WA, Duarte CA, Cleveland OH, Canton OH,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18 - 70+
Code: NCT04215809
Phase1, Recruiting
Active & Responsive
Type 1 Diabetes Extension Study
for
Type 1 Diabetes Mellitus, T1DM, T1D
Location: Seattle WA, San Francisco CA, Stanford CA, Aurora CO,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 8 - 35
Code: NCT02734277
Recruiting
Active & ResponsiveNew
Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
for
Type 1 Diabetes Mellitus
Location: Seattle WA, Aurora CO, Pittsburgh PA, New York NY,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 4 - 34
Code: NCT07216391
Phase2, Recruiting
Active & Responsive
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
for
Type 1 Diabetes Mellitus
Location: Seattle WA, San Francisco CA, Salt Lake City UT,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 8 - 45
Code: NCT07142252
Phase2, Recruiting
Active & Responsive
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
for
Long COVID, Sars-CoV-2 Infection, Coronavirus Infections,
Location: Seattle WA, San Francisco CA, Los Angeles CA, Aurora CO,
Sponsor: Wes Ely
Sex: All
Age: 18+
Code: NCT06631287
Phase3, Recruiting
Active & Responsive
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
for
Autosomal Dominant Polycystic Kidney Disease
Location: Seattle WA, Boise ID, Idaho Falls ID, San Francisco CA,
Sponsor: Calico Life Sciences LLC
Sex: All
Age: 18 - 55
Code: NCT06902558
Phase2, Recruiting
Active & Responsive
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)